Edwards Lifesciences CorpEW
Price$85.19Intrinsic value$74.9312% below price

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value $74.93median of 6 methods · middle span $55-$96based on filings through 30 Jun 2026
Market Price $85.19Price as of 1 Oct 2026
Margin of Safety -12.0%as of 1 Oct 2026

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Years 1–5: analyst growth pathFive-year total matches analyst consensus exactly. Year 1: 12.2% (near-term consensus, capped) · years 2–5: 14.5%/yr (balance of the path).14.0% per year
Years 6–10: glide to demonstrated growth
Per-year rates
Yr 613.0%Yr 711.5%Yr 810.0%Yr 98.6%Yr 107.1%
14.5% → 7.1%
Years 11–20: glide to long-run rate
Per-year rates
Yr 116.7%Yr 126.3%Yr 135.9%Yr 145.4%Yr 155.0%Yr 164.6%Yr 174.2%Yr 183.8%Yr 193.4%Yr 203.0%
7.1% → 3.0%
Beyond year 20: terminal growthPerpetual long-run rate3.0%
Historical EPS growth (multi-year median)median of 3 windows (5/6/7y)7.1%
Discount rate (cost of equity) 9.0%
Volatility vs market (adjusted beta)0.90

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions Sandbox Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetEdwards Lifesciences CorpEWHealth Care
Valuation
P/E49.5×
P/S7.8×
P/B4.8×
EV / Revenue7.5×
EV / EBITDA—
Profitability
Gross margin77.8%
Operating margin22.3%
Net margin15.4%
FCF margin22.0%
Returns
ROE9.5%
ROA7.2%
ROIC12.1%
Growth
Revenue growth (YoY)19.7%
5-yr fwd EPS growth14.0%
Financial strength
Debt / Equity0.06×
Current ratio4.52×
Altman Z-Score12.6
Interest coverage—
Dividend yield—

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.